Phase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer.

by Takeshi Ishikawa, Satoshi Kokura, Tatsuji Enoki, Naoyuki Sakamoto, Tetsuya Okayama, Mitsuko Ideno, Junichi Mineno, Kazuko Uno, Naohisa Yoshida, Kazuhiro Kamada, Kazuhiro Katada, Kazuhiko Uchiyama, Osamu Handa, Tomohisa Takagi, Hideyuki Konishi, Nobuaki Yagi, Yuji Naito, Yoshito Itoh, Toshikazu Yoshikawa
Published 2014-01-01